Industry Focus
Healthcare: Is CVS Health's Anti-Tobacco Strategy Paying Off?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:13:05
- Mas informaciones
Informações:
Sinopsis
CVS's plan to boost prescription revenue by abandoning Tobacco might be panning out, and Regeneron's pricey new drug could become a multibillion blockbuster.
